Let's stop CKD
The blood test designed to predict the onset of chronic kidney disease up to four years before symptoms appear.
The blood test for the prediction of chronic kidney disease in people living with type 2 diabetes.
PromarkerD can predict the onset of disease before clinical symptoms appear.
Doctors can prescribe an early therapeutic treatment to slow or stop the onset of disease.
Kidneys remain healthier for longer, saving healthcare expenses and improving the quality of life for patients.
How the PromarkerD test works
A sample is drawn at clinic or pathology laboratory.
Laboratory uses standard technology platform (immunoassay) to measure plasma protein biomarkers.
Cloud-based algorithm calculates patient kidney disease risk score Patient is classified as LOW RISK, MODERATE RISK, or HIGH RISK.
Clinician delivers results to patient. A personalized intervention/ management plan is created.
Results and clinical intervention
Low risk
Low four-year risk of developing DKD
Moderate risk
Moderate four-year risk of developing DKD
High risk
High four-year risk of developing DKD
- Standard diabetes management
- More frequent monitoring
- Lifestyle optimization
- Avoidance of potentially nephrotoxic drugs
- Review of glycemic targets and non-glycemic risk factors
- Very close monitoring
- Intensive management strategies
- Utilization of therapeutic drugs